Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (31-40 of 384) with videos related to

Pageof 39
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 30, 2021
EGFR Tyrosine Kinase Inhibitor Monotherapy Should Remain the Standard First-Line Treatment in Advanced EGFR-Mutant NSCLCSophie Stock-Martineau, Frances A Shepherd
Lung Cancer (Amsterdam, Netherlands)|December 14, 2002
Second line chemotherapy for NSCLC: establishing a gold standardFrank V Fossella, Thomas Lynch, Frances A Shepherd
Journal of the National Cancer Institute|June 7, 2007
Serum proteomic classifier for predicting response to epidermal growth factor receptor inhibitor therapy: have we built a better mousetrap?Ming-Sound Tsao, Geoffrey Liu, Frances A Shepherd
The Lancet. Oncology|July 10, 2003
Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancerSrikala S Sridhar, Lesley Seymour, Frances A Shepherd
Clinical Lung Cancer|June 13, 2006
Epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer: impact of primary or secondary mutationsAkira Sakurada, Frances A Shepherd, Ming-Sound Tsao
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2016
Response to Yamamoto et alAlona Zer, Ming-Sound Tsao, Frances A Shepherd
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Lung cancer in 2013: state of the art therapy for metastatic diseaseFrances A Shepherd, Paul A Bunn, Luis Paz-Ares
Treatments in Respiratory Medicine|April 9, 2005
Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer : a realistic goal?Fiona H Blackhall, Frances A Shepherd, Kathy S Albain
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 23, 2013
[Immunotherapy for non-small cell lung cancer--novel approaches to improve patient outcome]Frances A Shepherd, Jean-Yves Douillard, George R Blumenschein
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2011
Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcomeFrances A Shepherd, Jean-Yves Douillard, George R Blumenschein
Pageof 39

Showing results (31-40 of 384) with videos related to

Sort By:
Pageof 39
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 30, 2021
EGFR Tyrosine Kinase Inhibitor Monotherapy Should Remain the Standard First-Line Treatment in Advanced EGFR-Mutant NSCLCSophie Stock-Martineau, Frances A Shepherd
Lung Cancer (Amsterdam, Netherlands)|December 14, 2002
Second line chemotherapy for NSCLC: establishing a gold standardFrank V Fossella, Thomas Lynch, Frances A Shepherd
Journal of the National Cancer Institute|June 7, 2007
Serum proteomic classifier for predicting response to epidermal growth factor receptor inhibitor therapy: have we built a better mousetrap?Ming-Sound Tsao, Geoffrey Liu, Frances A Shepherd
The Lancet. Oncology|July 10, 2003
Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancerSrikala S Sridhar, Lesley Seymour, Frances A Shepherd
Clinical Lung Cancer|June 13, 2006
Epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer: impact of primary or secondary mutationsAkira Sakurada, Frances A Shepherd, Ming-Sound Tsao
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2016
Response to Yamamoto et alAlona Zer, Ming-Sound Tsao, Frances A Shepherd
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Lung cancer in 2013: state of the art therapy for metastatic diseaseFrances A Shepherd, Paul A Bunn, Luis Paz-Ares
Treatments in Respiratory Medicine|April 9, 2005
Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer : a realistic goal?Fiona H Blackhall, Frances A Shepherd, Kathy S Albain
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 23, 2013
[Immunotherapy for non-small cell lung cancer--novel approaches to improve patient outcome]Frances A Shepherd, Jean-Yves Douillard, George R Blumenschein
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2011
Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcomeFrances A Shepherd, Jean-Yves Douillard, George R Blumenschein
Pageof 39